These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7767912)

  • 1. Intralesional alfa-2a interferon therapy for basal cell carcinoma.
    Doğan B; Harmanyeri Y; Baloğlu H; Oztek I
    Cancer Lett; 1995 May; 91(2):215-9. PubMed ID: 7767912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of intralesional interferon alfa-2a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma.
    Alpsoy E; Yilmaz E; Başaran E; Yazar S
    J Dermatol; 1996 Jun; 23(6):394-6. PubMed ID: 8708151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of aggressive basal cell carcinoma with intralesional interferon: evaluation of efficacy by Mohs surgery.
    Stenquist B; Wennberg AM; Gisslén H; Larkö O
    J Am Acad Dermatol; 1992 Jul; 27(1):65-9. PubMed ID: 1619079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional interferon therapy for basal cell carcinoma.
    Cornell RC; Greenway HT; Tucker SB; Edwards L; Ashworth S; Vance JC; Tanner DJ; Taylor EL; Smiles KA; Peets EA
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):694-700. PubMed ID: 2229497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of basal cell carcinoma of the nasal pyramid with intralesional interferon alfa-2b.
    Fernández-Vozmediano JM; Armario-Hita JC
    J Drugs Dermatol; 2010 Apr; 9(4):381-4. PubMed ID: 20514797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional interferon in basal cell carcinoma: how does it work?
    Buechner S; Wernli M; Bachmann F; Harr T; Erb P
    Recent Results Cancer Res; 2002; 160():246-50. PubMed ID: 12079220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of basal cell carcinoma with intralesional interferon.
    Georgouras K
    Australas J Dermatol; 1994; 35(1):47. PubMed ID: 7864996
    [No Abstract]   [Full Text] [Related]  

  • 8. Regional and intralesional treatment of invasive basal cell carcinoma with interferon alfa-n2b.
    DiLorenzo PA; Goodman N; Lansville F; Markel W
    J Am Acad Dermatol; 1994 Jul; 31(1):109-11. PubMed ID: 8021351
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon.
    Mozzanica N; Cattaneo A; Boneschi V; Brambilla L; Melotti E; Finzi AF
    Arch Dermatol Res; 1990; 282(5):311-7. PubMed ID: 2221983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional interferon therapy for basal cell carcinoma.
    Epstein E
    J Am Acad Dermatol; 1992 Jan; 26(1):142-3. PubMed ID: 1732331
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgery of basal cell carcinoma around the lacrimal canaliculus can be necessary after primary treatment with intralesional interferon alpha 2b.
    Huerva V; Mangues I
    Indian J Ophthalmol; 2008; 56(1):85-6. PubMed ID: 18158420
    [No Abstract]   [Full Text] [Related]  

  • 12. Intralesional interferon-alpha 2b treatment of basal cell carcinoma.
    Thestrup-Pedersen K; Jacobsen IE; Frentz G
    Acta Derm Venereol; 1990; 70(6):512-4. PubMed ID: 1981427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of basal cell carcinoma with intralesional interferon alpha-2a.
    LeGrice P; Baird E; Hodge L
    N Z Med J; 1995 May; 108(1000):206-7. PubMed ID: 7783992
    [No Abstract]   [Full Text] [Related]  

  • 14. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.
    Buechner SA
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):731-4. PubMed ID: 1869644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited.
    Kim KH; Yavel RM; Gross VL; Brody N
    Dermatol Surg; 2004 Jan; 30(1):116-20. PubMed ID: 14692941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with high-risk facial basal cell carcinoma treated with interferon.
    Sánchez V; Carpio E; Fardales VE; Martínez B; Arias AI; Brito E; Bermudez N; Rodríguez Y
    An Bras Dermatol; 2024; 99(3):391-397. PubMed ID: 38383261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas.
    Edwards L; Tucker SB; Perednia D; Smiles KA; Taylor EL; Tanner DJ; Peets E
    Arch Dermatol; 1990 Aug; 126(8):1029-32. PubMed ID: 2383027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma.
    Chimenti S; Peris K; Di Cristofaro S; Fargnoli MC; Torlone G
    Dermatology; 1995; 190(3):214-7. PubMed ID: 7599384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of basal cell carcinoma with intralesional interferon.
    Vinciullo C
    Australas J Dermatol; 1993; 34(1):36. PubMed ID: 8240187
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of basal cell carcinoma with intralesional interferon alpha: a case report and literature review.
    McDonald RR; Georgouras K
    Australas J Dermatol; 1992; 33(2):81-6. PubMed ID: 1294057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.